Literature DB >> 9399546

Increased levels of macrophage colony-stimulating factor, gamma interferon, and tumor necrosis factor alpha in sera of patients with Orientia tsutsugamushi infection.

H Iwasaki1, N Takada, T Nakamura, T Ueda.   

Abstract

Levels of macrophage colony-stimulating factor (nine of nine patients) and gamma interferon (six of nine patients) in serum were elevated above the range of normal in the acute phase of tsutsugamushi disease. Significant increases in levels of tumor necrosis factor alpha were observed during the convalescent phase in five patients, and they exceeded the levels observed during the acute phase. Hypercytokinemia appeared to be responsible for the emergence of the symptoms of tsutsugamushi disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9399546      PMCID: PMC230174          DOI: 10.1128/jcm.35.12.3320-3322.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

Review 1.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

2.  Haemolysis with rickettsiosis and glucose-6-phosphate dehydrogenase deficiency.

Authors:  D H Walker; D L Radisch; H N Kirkman
Journal:  Lancet       Date:  1983-07-23       Impact factor: 79.321

3.  Macrophages in resistance to rickettsial infection: macrophage activation in vitro for killing of Rickettsia tsutsugamushi.

Authors:  C A Nacy; M S Meltzer
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

4.  Release of soluble tumor necrosis factor receptors in Mediterranean spotted fever rickettsiosis.

Authors:  W V Kern; J Oristrell; F Segura-Porta; P Kern
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

5.  Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection.

Authors:  D M Williams; L F Bonewald; G D Roodman; G I Byrne; D M Magee; J Schachter
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

6.  Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum.

Authors:  J Taverne; N Matthews; P Depledge; J H Playfair
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

7.  Recombinant tumor necrosis factor enhances macrophage destruction of Trypanosoma cruzi in the presence of bacterial endotoxin.

Authors:  J J Wirth; F Kierszenbaum
Journal:  J Immunol       Date:  1988-07-01       Impact factor: 5.422

Review 8.  Classification of Rickettsia tsutsugamushi in a new genus, Orientia gen. nov., as Orientia tsutsugamushi comb. nov.

Authors:  A Tamura; N Ohashi; H Urakami; S Miyamura
Journal:  Int J Syst Bacteriol       Date:  1995-07

9.  Characterization of factors determining Rickettsia tsutsugamushi pathogenicity for mice.

Authors:  M G Groves; D J Kelly
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

10.  Serodiagnosis of tsutsugamushi fever (scrub typhus) by the indirect immunoperoxidase technique.

Authors:  S Yamamoto; Y Minamishima
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

View more
  15 in total

1.  Severity predictors in eschar-positive scrub typhus and role of serum osteopontin.

Authors:  Sang-Won Park; Chang-Seop Lee; Chi Kug Lee; Yee Gyung Kwak; Chisook Moon; Baek-Nam Kim; Eu Suk Kim; Jae Myung Kang; Myoung-don Oh
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

2.  Subacute painful thyroiditis accompanied by scrub typhus infection.

Authors:  Sun hee Kim; Sunhee Kim; Tae Sun Park; Hong Sun Baek; Heung Yong Jin
Journal:  Endocrine       Date:  2013-04-07       Impact factor: 3.633

3.  The Obligate Intracellular Bacterium Orientia tsutsugamushi Targets NLRC5 To Modulate the Major Histocompatibility Complex Class I Pathway.

Authors:  Kyle G Rodino; Haley E Adcox; Rebecca K Martin; Vaidehi Patel; Daniel H Conrad; Jason A Carlyon
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

4.  Fulminant Japanese spotted fever associated with hypercytokinemia.

Authors:  H Iwasaki; F Mahara; N Takada; H Fujita; T Ueda
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

5.  Significantly higher cytokine and chemokine levels in patients with Japanese spotted fever than in those with Tsutsugamushi disease.

Authors:  Katsunori Tai; Hiromichi Iwasaki; Satoshi Ikegaya; Nobuhiro Takada; Yukiko Tamaki; Kenji Tabara; Takanori Ueda
Journal:  J Clin Microbiol       Date:  2014-03-26       Impact factor: 5.948

6.  Expression of chemokine genes in human dermal microvascular endothelial cell lines infected with Orientia tsutsugamushi.

Authors:  N H Cho; S Y Seong; M S Choi; I S Kim
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

7.  Comparison of Lethal and Nonlethal Mouse Models of Orientia tsutsugamushi Infection Reveals T-Cell Population-Associated Cytokine Signatures Correlated with Lethality and Protection.

Authors:  Alison Luce-Fedrow; Suchismita Chattopadhyay; Teik-Chye Chan; Gregory Pearson; John B Patton; Allen L Richards
Journal:  Trop Med Infect Dis       Date:  2021-07-02

8.  Activation of indoleamine 2,3-dioxygenase in patients with scrub typhus and its role in growth restriction of Orientia tsutsugamushi.

Authors:  Thanavadee Prachason; Kanittha Konhan; Piyapat Pongnarin; Somruedee Chatsiricharoenkul; Yupin Suputtamongkol; Chanin Limwongse
Journal:  PLoS Negl Trop Dis       Date:  2012-07-31

Review 9.  Approaches to vaccines against Orientia tsutsugamushi.

Authors:  Gustavo Valbuena; David H Walker
Journal:  Front Cell Infect Microbiol       Date:  2013-01-04       Impact factor: 5.293

10.  Cytokine network in scrub typhus: high levels of interleukin-8 are associated with disease severity and mortality.

Authors:  Elisabeth Astrup; Jeshina Janardhanan; Kari Otterdal; Thor Ueland; John A J Prakash; Tove Lekva; Øystein A Strand; O C Abraham; Kurien Thomas; Jan Kristian Damås; Prasad Mathews; Dilip Mathai; Pål Aukrust; George M Varghese
Journal:  PLoS Negl Trop Dis       Date:  2014-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.